Name: ORGANON & CO (OGN) Stock
Brand: ORGANON & CO
Rating: 3.5 (3 reviews)

OGN Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Chartmill - Mentions: IRBT PRE DYN SOHO ...

Which stocks are moving on Monday?

14 days ago - By: Chartmill - Mentions: IRBT GGAL BMA DYN ...

Keep an eye on the top gainers and losers in Monday's session.

2 days ago - By: Organon & Co.

New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities

2 days ago - By: Kahn Swick & Foti, LLC

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

3 days ago - By: Benzinga

A Look at Organon's Upcoming Earnings Report

3 days ago - By: Organon & Co.

Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie

4 days ago - By: Organon & Co.

Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025

13 days ago - By: Kahn Swick & Foti, LLC

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

14 days ago - By: Benzinga - Mentions: DYN PRE GNTA RNA ...

12 Health Care Stocks Moving In Monday's Intraday Session

14 days ago - By: Chartmill - Mentions: IRBT GGAL BMA UAMY ...

Which stocks are gapping on Monday?

14 days ago - By: Chartmill - Mentions: GGAL BMA PRE SOHO ...

These stocks are moving in today's pre-market session

14 days ago - By: Stocktwits - Mentions: AVUS EAOR

Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices

14 days ago - By: Organon

Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation

17 days ago - By: Zacks Investment Research

Organon (OGN) Laps the Stock Market: Here's Why

18 days ago - By: Zacks Investment Research - Mentions: TDOC

Organon (OGN) Earnings Expected to Grow: Should You Buy?

23 days ago - By: Zacks Investment Research

Organon (OGN) Stock Declines While Market Improves: Some Information for Investors

a month ago - By: Zacks Investment Research

Organon (OGN) Outperforms Broader Market: What You Need to Know

2 months ago - By: Zacks Investment Research

Organon (OGN) Stock Declines While Market Improves: Some Information for Investors

2 months ago - By: Kuehn Law, PLLC

Kuehn Law Encourages Investors of Organon & Co. to Contact Law Firm

2 months ago - By: Organon & Co.

US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

2 months ago - By: Yahoo Finance

ORGANON & CO (OGN) Stock News

OGN Latest News, Press Relases and Analysis

Which stocks are moving on Monday?

Keep an eye on the top gainers and losers in Monday's session.

New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

A Look at Organon's Upcoming Earnings Report

Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie

Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

12 Health Care Stocks Moving In Monday's Intraday Session

Which stocks are gapping on Monday?

These stocks are moving in today's pre-market session

Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices

Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation

Organon (OGN) Laps the Stock Market: Here's Why

Organon (OGN) Earnings Expected to Grow: Should You Buy?

Organon (OGN) Stock Declines While Market Improves: Some Information for Investors

Organon (OGN) Outperforms Broader Market: What You Need to Know

Organon (OGN) Stock Declines While Market Improves: Some Information for Investors

Kuehn Law Encourages Investors of Organon & Co. to Contact Law Firm

US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women’s Health Portfolio